Lenox Wealth Advisors’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$8K Sell
77
-26
-25% -$3.05K ﹤0.01% 515
2021
Q4
$12K Buy
103
+26
+34% +$2.89K ﹤0.01% 485
2021
Q3
$8K Hold
77
﹤0.01% 501
2021
Q2
$9K Buy
77
+34
+79% +$4.08K ﹤0.01% 486
2021
Q1
$5K Buy
+43
New +$4.67K ﹤0.01% 499
2018
Q3
Sell
-110
Closed -$11K 446
2018
Q2
$11K Sell
110
-35
-24% -$3.69K ﹤0.01% 338
2018
Q1
$15K Buy
145
+110
+314% +$11.1K ﹤0.01% 299
2017
Q4
$3K Buy
+35
New +$3.18K ﹤0.01% 281
2015
Q4
Sell
-158
Closed -$10K 521
2015
Q3
$10K Buy
158
+34
+27% +$2.51K ﹤0.01% 179
2015
Q2
$10K Hold
124
﹤0.01% 137
2015
Q1
$9K Hold
124
﹤0.01% 165
2014
Q4
$9K Sell
124
-111
-47% -$8.78K ﹤0.01% 173
2014
Q3
$19K Hold
235
0.01% 129
2014
Q2
$21K Buy
235
+124
+112% +$10.8K 0.01% 101
2014
Q1
$10K Sell
111
-52
-32% -$4.26K 0.01% 127
2013
Q4
$13K Buy
163
+52
+47% +$4.04K 0.01% 146
2013
Q3
$9K Hold
111
0.01% 107
2013
Q2
$8K Buy
+111
New +$7.74K 0.01% 126

Other funds holding EMN

Lenox Wealth Advisors's EMN Position: Q1 2022 in Review

Lenox Wealth Advisors reduced its Eastman Chemical (EMN) stake by 25% in Q1 2022, selling an estimated $3.05K and leaving 77 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #515.

Lenox Wealth Advisors first reported a position in EMN in Q2 2013 and has held it in 18 quarters since. The position peaked at $21K in Q2 2014. 752 funds tracked by Wall St. Rank hold EMN as of Q1 2022.

  • Lenox Wealth Advisors held 77 shares of Eastman Chemical worth $8K as of Q1 2022.
  • Lenox Wealth Advisors sold 26 Eastman Chemical shares in Q1 2022, an estimated $3.05K.
  • Eastman Chemical made up ﹤0.01% of Lenox Wealth Advisors's portfolio in Q1 2022, its #515 holding.
  • Lenox Wealth Advisors first reported a position in Eastman Chemical in Q2 2013 and has held it in 18 quarters since.
  • Lenox Wealth Advisors's Eastman Chemical position peaked at $21K in Q2 2014.
  • 752 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2022.

Based on Lenox Wealth Advisors's 13F filing for Q1 2022, filed 14 Apr 2022.